What can we learn from the SARS-COV-2 pandemic about the value of specific radiological examinations?

被引:5
|
作者
Hofmann, Bjorn [1 ,2 ]
Andersen, Eivind Richter [1 ]
Kjelle, Elin [1 ]
机构
[1] Norwegian Univ Sci & Technol NTNU Gjovik, Inst Hlth Sci, POB 191, N-2802 Gjovik, Norway
[2] Univ Oslo, Ctr Med Eth, Oslo, Norway
关键词
Low-value care; Appropriateness; Choosing wisely; Ethics; Covid-19; SARS-COV-2; MEDICAL-CARE; COVID-19; OVERUSE;
D O I
10.1186/s12913-021-07190-w
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background The SARS-COV-2 pandemic provides a natural intervention to assess practical priority setting and internal evaluation of specific health services, such as radiological services. Norway makes an excellent case as it had a very low infection rate and very few cases of COVID-19. Accordingly, the objective of this study is to use the changes in performed outpatient radiological examinations during the first stages of the SARS-COV-2 pandemic to assess the practical evaluation of specific radiological examinations in Norway. Methods Data was collected retrospectively from the Norwegian Health Economics Administration (HELFO) in the years 2015-2020. Data included the number of performed outpatient imaging examinations at public hospitals and private imaging centers in Norway and was divided in to three periods based on the level of restrictions on elective health services. Results were analyzed with descriptive statistics. Results In the first period there was a 45% reduction in outpatient radiology compared to the same time period in 2015-2019 while in period 2 and 3 there was a 25 and 6% reduction respectively. The study identified a list of specific potential low-value radiological examinations. While some of these are covered by the Choosing Wisely campaign, others are not. Conclusion By studying the priority setting practice during the initial phases of the pandemic this study identifies a set of potential low value radiological examinations during the initial phases of the SARS-COV-2 pandemic. These examinations are candidates for closer assessments for health services quality improvement.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] What we have to know about corticosteroids use during Sars-Cov-2 infection
    F. Ferraù
    F. Ceccato
    S. Cannavò
    C. Scaroni
    [J]. Journal of Endocrinological Investigation, 2021, 44 : 693 - 701
  • [42] Apoptosis induced by SARS-CoV-2: can we target it?
    Donia, Ahmed
    Bokhari, Habib
    [J]. APOPTOSIS, 2021, 26 (1-2) : 7 - 8
  • [43] Drugs against SARS-CoV-2: What do we know about their mode of action?
    Valle, Coralie
    Martin, Baptiste
    Touret, Franck
    Shannon, Ashleigh
    Canard, Bruno
    Guillemot, Jean-Claude
    Coutard, Bruno
    Decroly, Etienne
    [J]. REVIEWS IN MEDICAL VIROLOGY, 2020, 30 (06) : 1 - 10
  • [44] What we have to know about corticosteroids use during Sars-Cov-2 infection
    Ferrau, F.
    Ceccato, F.
    Cannavo, S.
    Scaroni, C.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2021, 44 (04) : 693 - 701
  • [45] Apoptosis induced by SARS-CoV-2: can we target it?
    Ahmed Donia
    Habib Bokhari
    [J]. Apoptosis, 2021, 26 : 7 - 8
  • [46] SARS-CoV-2 testing in travellers: Can we be smarter?
    Brophy, James M.
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2022, 194 (01) : E20 - E20
  • [47] SARS-CoV-2; What We Know so far
    Rajani, Huda Fatima
    Alshaikh, Fatima Ahmed
    Anushiravani, Amir
    [J]. ARCHIVES OF IRANIAN MEDICINE, 2020, 23 (07) : 498 - 502
  • [48] WHAT CAN WE LEARN ABOUT PICTURES FROM THE BLIND
    KENNEDY, JM
    [J]. AMERICAN SCIENTIST, 1983, 71 (01) : 19 - 26
  • [49] BCG and SARS-CoV-2 What Have We Learned?
    Kulesza, Jakub
    Kulesza, Ewelina
    Kozinski, Piotr
    Karpik, Wojciech
    Broncel, Marlena
    Fol, Marek
    [J]. VACCINES, 2022, 10 (10)
  • [50] WHAT CAN WE LEARN FROM (AND ABOUT) GLOBAL AGING?
    Kapteyn, Arike
    [J]. DEMOGRAPHY, 2010, 47 : S191 - S209